Immunotherapy where human t-cells are engineered with chimeric antigen receptors enhance anti-tumor activity. Natural killer (NK)-CAR-iPSC-NK cells now provide standardized, targeted "off-the-shelf" lymphocytes for anti-cancer immunotherapy.
from Medindia Health News https://ift.tt/2KuOmcs
No comments:
Post a Comment